MedTrace Logo

Validation of Two New Questionnaires for Dupuytren's Disease

NCT01446432 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2015-04-03

No results posted yet for this study

Summary

A study to validate two newly developed questionnaires for Dupuytren's Disease. The objective is to develop a patient specific outcomes tool for Dupuytren's Disease. While there are standard and validated questionnaire instruments used to measure health related quality of life and function, they do not address patient specific issues. The investigators will also pilot a treatment/disease specific satisfaction questionnaire for Xiaflex use for Dupuytren's Disease.

Conditions

  • Dupuytren's Disease

Sponsors & Collaborators

  • Auxilium Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Robert Hotchkiss

    lead OTHER

Principal Investigators

  • Robert N Hotchkiss, MD · Hosptial for Special Surgery

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01446432 on ClinicalTrials.gov